Buy Galmed Pharmaceuticals Stock | GLMD Stock Price & Latest News | Public.com
GLMD

Galmed Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View Galmed Pharmaceuticals (GLMD) stock trends here

    About GLMD

    Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecul...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.16
    -0.32
    -0.48
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.36

    Actual EPS
    Q2 2021

    Stats

    Market Cap$77M
    Volume170,62k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$6.29
    1 Year Low$2.96
    Open$3.16
    High$3.19
    Low$3.03

    Buy any stock with any amount of money.

    Download the App
    Download the app